Medtronic has raised its fiscal year 2026 (FY26) profit outlook to 4.5%, up from a previous target of 4%, amid strong growth ...

Medtronic (MDT) recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income ...

Med-tech company Medtronic (MDT) announced on Tuesday that its board of directors has appointed industry veterans John ...

Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic (MDT) stock in focus as the company raises FY2025 earnings outlook amid Q1 outperformance and reduced tariff impact ...

Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

Medtronic develops and manufactures a wide range of medical devices, including implantable cardiac pacemakers, heart valves, neurostimulation systems, insulin pumps, and surgical robotics platforms.

Medtronic plc (NYSE: MDT) has released its financial results for the first quarter of fiscal year 2026, showcasing a notable ...

Medtronic posts stronger Q1 results, raises fiscal 2026 outlook, adds new board members, and sets 2026 Investor Day amid ...

Medtronic plc MDT reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.26, which rose 2.4% from the ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...